Clinical Trials Filters

Trials in Diseases and Abnormalities at or Before Birth

708 Studies Found
Hoffmann-La Roche

Location: China

Status: Recruiting

Phase: Phase 1

Results: N/A

Start Date: 20 Mar, 2018

Completion Date: 30 Oct, 2018

Healthy VolunteersHemophilia A
Bayer

Location: Italy

Status: Active, not recruiting

Results: N/A

Start Date: 14 Apr, 2016

Completion Date: 20 Mar, 2018

Hemophilia A
Pfizer

Location: Canada, United States

Status: Recruiting

Phase: Phase 3

Results: N/A

Start Date: 01 Jun, 2015

Completion Date: 01 Nov, 2018

AnemiaSickle Cell
Bayer

Location: Argentina, Austria, Belgium, Bulgaria, Canada, Greece, Israel, Italy, Lithuania, Netherlands, New Zealand, Norway, Poland, Romania, Spain, United Kingdom, United States

Status: Active, not recruiting

Phase: Phase 3

Results: N/A

Start Date: 29 May, 2013

Completion Date: 17 Feb, 2020

Hemophilia A
National Institutes of Health Clinical Center (CC)

Location: United States

Status: Active, not recruiting

Phase: Phase 1/Phase 2

Results: N/A

Start Date: 09 Sep, 2009

Completion Date: 01 Aug, 2018

Peripheral Blood Stem Cell TransplantationAnemiaSickle CellGraft-Versus-Host DiseaseSirolimus (Rapamune )Alemtuzumab (Campath )
National Institutes of Health Clinical Center (CC)

Location: United States

Status: Completed

Results: N/A

Start Date: 29 Sep, 2008

Completion Date: 29 Jun, 2017

Congenital AbnormalitiesBirth DefectsCongenital Defects
National Institutes of Health Clinical Center (CC)

Location: United States

Status: Enrolling by invitation

Results: N/A

Start Date: 09 Oct, 2007

Sickle Cell TraitSickle Cell DiseaseSickle Cell Anemia
Shire

Location: United States

Status: Recruiting

Phase: Phase 1/Phase 2

Results: N/A

Start Date: 01 Mar, 2018

Completion Date: 30 Jun, 2022

Hemophilia A
Hampshire Hospitals NHS Foundation Trust

Location: United Kingdom

Status: Completed

Results: N/A

Start Date: 01 Sep, 2015

Completion Date: 30 Nov, 2017

Hemophilia A
Holterman, Ai-Xuan, M.D.

Location: United States

Status: Enrolling by invitation

Phase: Early Phase 1

Results: N/A

Start Date: 15 Jan, 2018

Completion Date: 31 Jan, 2019

Biliary Atresia